Net Net Stock Overview

Subscribe

To see hundreds more international net nets, consider subscribing

Overview

Sonoma Pharmaceuticals Inc
Healthcare
P/NCAV
0.12x
Ticker
SNOA
Exchange
NASDAQ
Country
United States
Close
0.16 $
Mkt Cap
539646 $
EV
-1.8M $
NCAV Burn Rate
-59.8%
Current Ratio
4.07
Debt/Equity
0.01
EV/REV
-0.14x
EV/EBIT
0.4x
EV/FCF
0.3x
Dilution
41.1% p.A
Total Net Income
-48.6M $
Cheapness
100.0%
Sonoma Pharmaceuticals, Inc. is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, animal health care, eye care, oral care and dermatological conditions. The Company-s product offerings include Regenacyn Advanced Scar Gel, Regenacyn Plus Scar Gel, Rejuvacyn Advanced Skin Repair Cooling Mist, Pediacyn Skin Care, Microcyn, Ocucyn Eyelid and Eyelash Cleanser, Microdacyn60 Oral Care, Podiacyn Advanced Everyday Foot Care, and MicrocynAH. Regenacyn Advanced Scar Gel helps to improve the overall appearance of scars while reducing pain, itch, redness, and inflammation. Regenacyn Plus is a prescription-strength scar gel which is available as an office dispense product through dermatology practices and medical spas. Pediacyn is a pediatric dermatology and wound care product for over-the-counter use. MicrocynAH is a HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.

Profitability

positive values --- Average negative values

Margins

--- Average

Valuation

positive values --- Average negative values

Dilution

--- Average